---
document_datetime: 2023-09-21 20:03:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zoledronic-acid-medac-epar-all-authorised-presentations_en.pdf
document_name: zoledronic-acid-medac-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7300444
conversion_datetime: 2025-12-23 03:04:00.856735
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name       | Strength    | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                     |
|------------------|-----------------------|-------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------------------------|
| EU/1/12/779/004  | Zoledronic acid medac | 4 mg/100 ml | Solution for infusion | Intravenous use           | bottle (glass)        | 100 ml                    | 1 bottle                      |
| EU/1/12/779/005  | Zoledronic acid medac | 4 mg/100 ml | Solution for infusion | Intravenous use           | bottle (glass)        | 100 ml                    | 4 (4 x 1) bottles (multipack) |